Evfm earnings outlook
WebMay 04, 2024. $2.47. $1.66. -32.79%. Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change. Web2 days ago · The average analyst rating for EVFM stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the …
Evfm earnings outlook
Did you know?
WebMay 04, 2024. $2.47. $1.66. -32.79%. Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings … WebView all EVFM assets, cash, debt, liabilities, shareholder equity and investments. ... 1:40p Barron's Smucker Rises on Earnings, Boost to Full-Year Outlook 1:38p Dow attempts to bounce back ...
WebDec 1, 2024 · NasdaqCM:EVFM Earnings and Revenue Growth December 1st 2024. We like that insiders have been buying shares in the last twelve months. Even so, future earnings will be far more important to whether ... WebJun 4, 2024 · NasdaqCM:EVFM Earnings and Revenue Growth June 4th 2024. We like that insiders have been buying shares in the last twelve months. Having said that, most people consider earnings and revenue growth ...
WebThe page provides an overview of the company's financial health, with key data points such as the current stock price, earnings per share, and revenue compared against the forecast. Earnings Insights WebThe Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Evofem Biosciences Inc’s P/E ratio is 0.00.
WebEvofem Biosciences Inc's (NASDAQ: EVFM) Q2 Phexxi sales increased 42% Y/Y to $6.0 million, reflecting higher ex-factory sales and lower gross-to-net adjustments of 40%. The …
WebApr 11, 2024 · Evofem Biosciences Stock Earnings Report. Current P/E ratio: -0.0018 Price (Mar 27, 2024, EOD): $0.0230 (Find current average P/E ratios for all sectors below ) lanark heights long term careWebEvofem Biosciences Inc's (NASDAQ: EVFM) Q2 Phexxi sales increased 42% Y/Y to $6.0 million, reflecting higher ex-factory sales and lower gross-to-net adjustments of 40%. lanark highlands real estateWebAverage Return. +98.14%. reiterated a sell rating 6 months ago. Copying Jeffrey Hung 's trades and holding each position for 1 Year would result in +100.00% of your … lanarkhighlands.isivote.comWebEvofem Biosciences, Inc. (EVFM) latest earnings report: revenue, EPS, surprise, history, news and analysis. lanark health clinicWebApr 13, 2024 · The earnings per share stood at -4.57 with a YoY at -14.16%. Net Income for the company stood at $-125.98M with a YoY of -276.89%. The Free Cash flow of the company stands at -$27M with a YoY of 50.41% which has improved by $7M as compared to the last quarter but still gives worrying signs as the company is not making that much … lanark highlands public libraryWebAug 11, 2024 · Shares of Evofem Biosciences (NASDAQ:EVFM) decreased 2.7% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per … helping elderly at homeWebApr 6, 2024 · Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q2 2024 Results - Earnings Call Transcript. SA Transcripts Wed, Aug. 11, 2024. helping elderly clipart